Chaney Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$360K Sell
855
-27
-3% -$10.8K 0.1% 33
2026
Q2
$319K Buy
882
+36
+4% +$12.3K 0.1% 35
2026
Q1
$298K Hold
846
– – 0.1% 33
2025
Q4
$277K Buy
846
+75
+10% +$23.8K 0.1% 34
2025
Q3
$218K Buy
+771
New +$224K 0.08% 36

Other funds holding AMGN

Chaney Capital Management's AMGN Position: Q3 2026 in Review

Chaney Capital Management reduced its Amgen (AMGN) stake by 3.1% in Q3 2026, selling an estimated $10.8K and leaving 855 shares worth $360K. The position accounts for 0.1% of the portfolio, ranked #33.

Chaney Capital Management first reported a position in AMGN in Q3 2025 and has held it in 5 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Chaney Capital Management held 855 shares of Amgen worth $360K as of Q3 2026.
  • Chaney Capital Management sold 27 Amgen shares in Q3 2026, an estimated $10.8K.
  • Amgen made up 0.1% of Chaney Capital Management's portfolio in Q3 2026, its #33 holding.
  • Chaney Capital Management first reported a position in Amgen in Q3 2025 and has held it in 5 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Chaney Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.